Fastest Ever Review For A Product In EMA's PRIME Scheme
Executive Summary
The European Medicines Agency says that when it comes to products developed under its priority medicines scheme, dialog is crucial to ensure that the data generated for marketing applications are sufficiently robust and mature and facilitate a timely review.